Xerient
2 known investors
Find your way into Xerient
Sign up to see every warm intro you have to Xerient
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Xerient team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Xerient do?
- Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
- Who founded Xerient?
- Xerient was founded by Guy Yachin, Dr. Michael Shtein, Prof. Cullen Taniguchi.
- Who are Xerient's investors?
- Xerient's investors include Peregrine Ventures, SIBF (Southern Israel Bridging Fund) VC.



